Large-scale testing (Phase 3)Study completedNCT01400139
What this trial is testing
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
Who this might be right for
Chronic Nonmalignant and Nonneuropathic Pain
Purdue Pharma LP 922